Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First Patient Dosed in Trial of Ultra-Concentrated Rapid Acting Insulin Candidate for Diabetes

americanpharmaceuticalreviewDecember 17, 2020

Tag: Insulin , AT278 , Clinical Trial , Diabetes

PharmaSources Customer Service